PODCAST
Steven Rosenberg
Dr. Steven A. Rosenberg is the Chief of Surgery at the National Cancer Institute in Bethesda, Maryland. He pioneered the development of immunotherapy that has resulted in the first effective immunotherapies for selected patients with advanced cancer. Dr. Rosenberg also pioneered the development of gene therapy and was the first to successfully insert foreign genes into humans and to conduct clinical studies of the gene therapy of cancer. He received his medical degree from Johns Hopkins and his Ph.D. in biophysics from Harvard. After his residency training at Brigham Hospital in Boston, he joined the National Cancer Institute as its Chief of Surgery at age 34, a position he continues to hold today. Dr. Rosenberg is credited with developing the use of IL-2 and immune cells for the treatment of patients with melanoma in a procedure termed adoptive cell transfer. He has shown that expanding immune cells in the lab can be used to treat patients with melanoma. The first published study in 2
Episodes
-
Steven Rosenberg - Part 1 (SD)
Dr. Steven A. Rosenberg is the Chief of Surgery at the National Cancer Institute in Bethesda, Maryland. He pioneered the development of immunotherapy that has resulted in the first effective immunotherapies for selected patients with advanced cancer. Dr. Rosenberg also pioneered the development…
more -
Steven Rosenberg - Part 2 (SD)
Dr. Steven A. Rosenberg is the Chief of Surgery at the National Cancer Institute in Bethesda, Maryland. He pioneered the development of immunotherapy that has resulted in the first effective immunotherapies for selected patients with advanced cancer. Dr. Rosenberg also pioneered the development…
more -
Steven Rosenberg - Part 3 (SD)
Dr. Steven A. Rosenberg is the Chief of Surgery at the National Cancer Institute in Bethesda, Maryland. He pioneered the development of immunotherapy that has resulted in the first effective immunotherapies for selected patients with advanced cancer. Dr. Rosenberg also pioneered the development…
more -
Steven Rosenberg - Part 1 (HD)
Dr. Steven A. Rosenberg is the Chief of Surgery at the National Cancer Institute in Bethesda, Maryland. He pioneered the development of immunotherapy that has resulted in the first effective immunotherapies for selected patients with advanced cancer. Dr. Rosenberg also pioneered the development…
more -
Steven Rosenberg - Part 2 (HD)
Dr. Steven A. Rosenberg is the Chief of Surgery at the National Cancer Institute in Bethesda, Maryland. He pioneered the development of immunotherapy that has resulted in the first effective immunotherapies for selected patients with advanced cancer. Dr. Rosenberg also pioneered the development…
more -
Steven Rosenberg - Part 3 (HD)
Dr. Steven A. Rosenberg is the Chief of Surgery at the National Cancer Institute in Bethesda, Maryland. He pioneered the development of immunotherapy that has resulted in the first effective immunotherapies for selected patients with advanced cancer. Dr. Rosenberg also pioneered the development…
more
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Dr. Steven A. Rosenberg is the Chief of Surgery at the National Cancer Institute in Bethesda, Maryland. He pioneered the development of immunotherapy that has resulted in the first effective immunotherapies for selected patients with advanced cancer. Dr. Rosenberg also pioneered the development of gene therapy and was the first to successfully insert foreign genes into humans and to conduct clinical studies of the gene therapy of cancer. He received his medical degree from Johns Hopkins and his Ph.D. in biophysics from Harvard. After his residency training at Brigham Hospital in Boston, he joined the National Cancer Institute as its Chief of Surgery at age 34, a position he continues to hold today. Dr. Rosenberg is credited with developing the use of IL-2 and immune cells for the treatment of patients with melanoma in a procedure termed adoptive cell transfer. He has shown that expanding immune cells in the lab can be used to treat patients with melanoma. The first published study in 2
Loading similar podcasts...
Frequently Asked Questions
How many episodes does Steven Rosenberg have?
Steven Rosenberg currently has 6 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is Steven Rosenberg about?
Dr. Steven A. Rosenberg is the Chief of Surgery at the National Cancer Institute in Bethesda, Maryland. He pioneered the development of immunotherapy that has resulted in the first effective immunotherapies for selected patients with advanced cancer. Dr. Rosenberg also pioneered the development of...
How often does Steven Rosenberg release new episodes?
Steven Rosenberg has 6 episodes. Check the episode list to see recent publication dates and frequency.
Where can I listen to Steven Rosenberg?
You can listen to Steven Rosenberg on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
URL copied to clipboard!